許 藝瓊

Medicine & Life Sciences

1. Thyroid Neoplasms 100%
2. Papillary Thyroid Cancer 94%
3. Adenocarcinoma of Lung 86%
4. Neoplasms 63%
5. 1,6-Bis(4-(4-amino-3-hydroxyphenoxy)phenyl)diamantane 45%
6. hydroxygenkwanin 40%
7. Lung Neoplasms 39%
8. Mutation 36%
9. Genes 35%
10. Non-Small Cell Lung Carcinoma 32%
11. Genome 29%
12. Growth 28%
13. Neoplasm Metastasis 28%
14. Thyroid Gland 25%
15. Cell Movement 25%
16. Recurrence 24%
17. HCT116 Cells 24%
18. Survival 23%
19. 2,2-bis(4-(4-amino-3-hydroxyphenoxy)phenyl)adamantane 22%
20. Cell Cycle Checkpoints 22%
21. Gene Expression 21%
22. Apoptosis 19%
23. ErbB Receptors 19%
24. Caspase 3 19%
25. Parathyroid Hormone 18%
26. Atlases 17%
27. Meta-Analysis 17%
28. Retinoid X Receptor gamma 17%
29. sodium-iodide symporter 16%
30. Leptin Receptors 15%
31. Cell Line 15%
32. Mitochondria 15%
33. Papillary Thyroid Microcarcinoma 14%
34. Ferroptosis 14%
35. 2-Methoxyestradiol 14%
36. Momordica charantia 14%
37. Endoplasmic Reticulum Stress 14%
38. Anoikis 14%
39. integrin-linked kinase 14%
40. High-Throughput Nucleotide Sequencing 14%
41. Integrins 14%
42. Adiponectin Receptors 14%
43. Guanosine Monophosphate 14%
44. perchlorate 14%
45. Alleles 13%
46. Mupirocin 13%
47. thiocyanate 13%
48. Epithelial-Mesenchymal Transition 13%
49. In Vitro Techniques 13%
50. Colorectal Neoplasms 12%